Efficacy and Safety of Tocilizumab in Adult’s Still Disease
Condition(s):Adult’s Still DiseaseLast Updated:October 27, 2009Unknown status
Hide Studies Not Open or Pending
Condition(s):Adult’s Still DiseaseLast Updated:October 27, 2009Unknown status
Condition(s):Adult Onset Still DiseaseLast Updated:February 11, 2021Completed
Condition(s):Adult-Onset Still´s DiseaseLast Updated:August 7, 2020Terminated
Condition(s):Adult Onset Still DiseaseLast Updated:February 2, 2021Unknown status
Condition(s):Adult-Onset Still’s Disease; AOSDLast Updated:September 21, 2023Withdrawn
Condition(s):Adult-Onset Still Disease; Critically IllLast Updated:September 20, 2018Completed
Condition(s):Adult-Onset Still’s DiseaseLast Updated:March 6, 2017Completed
Condition(s):Adult Onset Still’s DiseaseLast Updated:October 18, 2023Active, not recruiting
Condition(s):Macrophage Activation Syndrome; Lymphohistiocytosis, Hemophagocytic; Arthritis, Juvenile; Adult Onset Still DiseaseLast Updated:May 17, 2022Completed
Condition(s):Still’s Disease, Adult-OnsetLast Updated:December 6, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.